A former AstraZeneca board member has told Sky News that she thinks the company has been unfairly criticised over its handling of the vaccine rollout.
Professor Dame Nancy Rothwell, who served on the board until five years ago, said she imagined those inside the company would be feeling they have “had a bit of a hard time” as multiple countries have changed their advice on who should receive the jab.
It comes as the UK medicines regulator said that the under 30s should be offered an alternative to the AstraZeneca vaccine following reports of very rare blood clots.
SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews
Follow us on Twitter: https://twitter.com/skynews
Like us on Facebook: https://www.facebook.com/skynews
Follow us on Instagram: https://www.instagram.com/skynews
For more content go to http://news.sky.com and download our apps:
Apple: https://itunes.apple.com/gb/app/sky-news/id316391924?mt=8
Android https://play.google.com/store/apps/details?id=com.bskyb.skynews.android&hl=en_GB
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí https://www.youtube.com/channel/UCzG5BnqHO8oNlrPDW9CYJog